Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care


Huma Therapeutics Limited, a global digital health technology company advancing digital-first care delivery and research to help people live longer, fuller lives, today announced a new partnership with AstraZeneca to scale innovation for digital health. This agreement follows prior use cases executed between Huma and AstraZeneca, reflecting a shared ambition to improve clinical outcomes through digital health solutions to bridge the gap between patients and clinicians.

Read More

Next Post

Hartford HealthCare and Ibex Launch Research Initiative on AI-powered Solution to Improve Breast Cancer Diagnosis

Ibex Medical Analytics, a pioneer in artificial intelligence (AI)-powered cancer diagnostics, and Hartford HealthCare, a comprehensive and integrated healthcare system with more than 400 locations serving more than 17,000 people daily, announce a clinical research study involving Ibex’s Galen™ Breast, an AI solution helping physicians deliver high-quality diagnosis and improved care for breast […]